Morgan Health has unveiled its next investment, joining the latest funding round for Embold Health, a physician-led data analytics company. The healthcare arm of JPMorgan Chase will chip in $5 million ...

Relutrigine, a novel sodium channel modulator, is under FDA Priority Review for the treatment of pediatric SCN2A and SCN8A epileptic encephalopathies.

DUBLIN, Ohio & NASHVILLE, Tenn., June 17, 2025--(BUSINESS WIRE)--Quantum Health ("Quantum"), the creator of healthcare navigation, today announced the completion of its acquisition of Embold Health ...

Embold Edge Enables Employers and Health Plans to Launch an Alternative, Quality-Driven Health Plan Without Network or Carrier Disruption For years, employers and health plans have relied on price ...

Organizations are looking for ways to reduce the cost of care without sacrificing the quality of care for their workforce. Nashville-based Embold Health is working to set the standard in physician ...

Your donation today will help MinnPost continue to report on the news you need. MinnPost is now sharing the complete results of our 2024 Minnesota poll, a survey of political and economic questions ...

Embold Health Launches Embold Edge, The First National Quality-Driven Health Plan Designed to Reduce Waste and Lower Total Cost of Care Embold Edge Enables Employers and Health Plans to Launch an ...